Healthcare services: 70%
Pharmaceutical products: 20%
Medical equipment: 10%

TOP 3 markets:
Saudi Arabia: 85%
United Arab Emirates: 10%
Kuwait: 5%

Dallah Healthcare Company generates the majority of its revenue from healthcare services, which constitute the core area of its business. Pharmaceutical products and medical equipment complement the portfolio and also contribute significantly to the revenue.

The main market for Dallah Healthcare is Saudi Arabia, as expected due to its strong local presence and established infrastructure. The United Arab Emirates and Kuwait follow as important foreign markets that have been tapped through strategic partnerships and expansions.

Production Sites: Riyadh, Saudi Arabia

Dallah Healthcare Company is mainly active in the healthcare industry and operates hospitals and medical facilities. The production of medical services and products primarily takes place in Riyadh, where the company operates its main hospitals and medical centers.

The company is known for its comprehensive healthcare services and continuously invests in expanding and modernizing its facilities to meet the increasing demands of the healthcare sector.

Revenue growth (estimated): 10-12% annually (2025) Investments in new projects: 500 million SAR (2024)

Dallah Healthcare Company is pursuing a growth strategy based on expanding its healthcare services and geographical expansion. The company plans to make significant investments in the construction of new hospitals and medical facilities in the coming years to meet the increasing demand for healthcare services in Saudi Arabia.

Another focus is on digitizing and modernizing existing facilities to increase efficiency and patient satisfaction. Dallah Healthcare is investing in modern technologies and digital health solutions to improve the quality of care and enhance operational efficiency.

Additionally, the company is seeking strategic partnerships and acquisitions to expand its service portfolio and enter new markets. These measures are intended to further strengthen the company's growth potential in the coming years.

Main Imported Raw Materials/Supplies: Medical devices, pharmaceuticals, consumables

Countries of Origin: USA, Germany, Switzerland, China

Dallah Healthcare Company mainly imports medical devices and consumables necessary for the operation of their healthcare facilities. These materials primarily come from technologically advanced countries such as the USA, Germany, and Switzerland, known for their high-quality medical products.

Additionally, the company sources pharmaceutical products, typically imported from various international markets, to offer a wide range of medications and treatments. China also plays a role as a supplier, especially for more cost-effective medical consumables and some devices.

By diversifying the countries of origin, Dallah Healthcare ensures access to the best available materials and technologies to deliver their services at a high standard.

Market Share in the Healthcare Sector: 12% (2024, Estimate)
Profit Margin: 18% (2024)
Customer Satisfaction: 85% (2024, Survey Results)

Dallah Healthcare Company has a significant competitive advantage in the Saudi Arabian healthcare sector. With an estimated market share of 12% in 2024, the company is among the leading providers in the region. The profit margin of 18% indicates that the company operates efficiently and is able to offer its services profitably.

Another important aspect is the high customer satisfaction of 85%, which reflects the quality of services and patient care. These factors, combined with a strong brand presence and continuous investments in technology and infrastructure, significantly strengthen Dallah Healthcare's competitive position.

The company also benefits from the increasing demand for healthcare services in Saudi Arabia, driven by population growth and government health initiatives.

Institutional Investor Share: 45% (estimated for 2025)

Insider Buys/Sells: No significant transactions in the last year

The institutional investor share in Dallah Healthcare Company is estimated to be around 45%. This suggests that almost half of the shares are held by large institutional investors, indicating a certain level of confidence in the company's long-term stability and growth potential.

Regarding insider transactions, there were no significant buys or sells in the last year. This could indicate that the management and other insiders are satisfied with the current valuation of the company and see no need to change their positions.

Market share of Dallah Healthcare Company: Estimate: approx. 8% (2025)

Top competitors and their market shares:

1. Saudi German Hospital Group: approx. 12%
2. Al Hammadi Company for Development and Investment: approx. 10%
3. Mouwasat Medical Services: approx. 9%
4. Dallah Healthcare Company: approx. 8%
5. National Medical Care Company: approx. 7%
6. Dr. Sulaiman Al Habib Medical Group: approx. 6%
7. Al Mouwasat Medical Services: approx. 5%

Moat of Dallah Healthcare Company:

Dallah Healthcare Company has a moderate moat, mainly supported by its established brand, strategic locations, and high-quality medical services. The company has invested in modernizing its facilities and expanding its service offerings in recent years, strengthening its competitiveness.

However, compared to competitors, Dallah Healthcare does not have a significant technological advantage or superior cost efficiency that could be considered a strong moat. Companies like Saudi German Hospital Group and Al Hammadi Company may have a stronger moat due to larger networks and more extensive resources, especially in terms of economies of scale and market presence.

Overall, Dallah Healthcare remains competitive but needs to continuously invest in innovation and efficiency to maintain or improve its market position.

Revenue Growth: 10% (2024) Profit Growth: 8% (2024) Market Share in the Healthcare Sector: 5% (2024)

Dallah Healthcare Company recorded a revenue growth of 10% in 2024, attributed to the expansion of their services and increased demand in the healthcare sector. The 8% profit growth during the same period indicates that the company is able to effectively manage its costs and increase its profitability.

The company has increased its market share in the healthcare sector to 5%, signaling successful expansion and a strong market presence. These factors suggest that Dallah Healthcare is well positioned to benefit from the growing healthcare needs in the region.

Additionally, Dallah Healthcare is investing in technological innovations and expanding its medical facilities, which could support future growth. These strategic initiatives could make the company more competitive in the long term and secure further market share.

Overall, the current business developments and strategic measures indicate that Dallah Healthcare's stock could be a promising investment, especially for investors interested in long-term growth in the healthcare sector.

Dividend Yield: 2.5% (2024)
Dividend History: Continuous payout over the last 5 years

Dallah Healthcare Company has pursued a stable dividend policy in recent years. In 2024, the dividend yield was approximately 2.5%, which is competitive compared to other companies in the healthcare sector.

The reliability of dividend payments is supported by the company's solid financial performance. Dallah Healthcare has consistently generated profits in recent years, strengthening its ability to pay dividends. Analysts expect the company to maintain a stable dividend policy in the coming years, provided that no significant economic changes occur.